StonvexLoading…
StonvexCore line items from ABSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.27M | $215.00K | $2.80M | $2.15M | $1.77M |
Operating Income | Not available | $-30.85M | $-120.32M | $-89.28M | $-59.12M |
Net Income | Not available | $-29.60M | $-115.18M | $-85.62M | $-30.57M |
EPS (Diluted) | $-0.22 | $-0.19 | $-0.84 | $-0.65 | $-0.45 |
Total Assets | Not available | $195.59M | $216.30M | $244.99M | $209.89M |
Total Liabilities | Not available | $23.62M | $26.85M | $34.65M | $36.52M |
Cash & Equivalents | Not available | $8.63M | $20.02M | $9.48M | $38.02M |
Free Cash Flow OCF − CapEx | Not available | $-26.34M | $-94.03M | $-64.95M | $-38.96M |
Shares Outstanding | Not available | 152.96M | 136.78M | 132.11M | 126.04M |